ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 132791 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 132791; 2) Community: the network communities that were significantly associated with the response to NSC 132791; 3) Molecule: the relationships between components within communities and NSC 132791; 4) MDR: the compounds that were significantly associated with the NSC 132791.

NSC Compound Enrichment Correlation
NSC 672210 Null 0.00485717408280859 0.16415951
NSC 672868 Null 0.00485717408280859 0.19616315
NSC 717468 Null 0.00485717408280859 0.3880292
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.00485717408280859 0.43122565
NSC 731701 1[(4-n-butyloxyCarbonyl)piperazine-1-yl]diazene-1-ium-1,2-di olate 0.00485717408280859 -0.10107732
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.00485717408280859 0.14337408
NSC 362453 Butanedioic acid, mono[2-[3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl]ethyl] ester 0.0048681766467277 0.29878642
NSC 628811 Null 0.0048681766467277 0.31981741
NSC 678049 Null 0.0048681766467277 0.31127794
NSC 687527 Pyrazino[1,2-a]benzimidazole, 3-(4-methoxyphenyl)- 1-methylene-2-phenyl- 0.0048681766467277 0.34028962
Total:73  Current:9    [First] [Prev] [Next] [Last]